Clinical trial Recruiting at 1 site Observational Ages 18 to 85

Arterial wave energy and recovery after balloon pulmonary angioplasty for CTEPH

Official title: Arterial Wave Energy Flux and Multidimensional Recovery in Patients With Chronic Thromboembolic Pulmonary Hypertension Undergoing Balloon Pulmonary Angioplasty

Run by Istanbul Mehmet Akif Ersoy Educational and Training Hospital · NCT07522203 · Data updated 2026-11-12

This tests whether advanced pulmonary artery pressure wave analysis can track and predict recovery in adults (18–85) with chronic thromboembolic pulmonary hypertension treated with balloon pulmonary angioplasty.

More Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH) trials

Quick facts

Study typeObservational
Ages18 Years to 85 Years
SexAll
Enrollment70 (estimated)
SponsorIstanbul Mehmet Akif Ersoy Educational and Training Hospital
Government
Locations1 site (Istanbul)
StatusRecruiting
StartedMarch 10, 2026
Main results expectedApril 1, 2028
Study endsMay 1, 2028
Registry record updatedApril 13, 2026
Trial IDNCT07522203 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–85 with confirmed CTEPH judged eligible for BPA (technically inoperable or persistent/recurrent PH after PEA) and hemodynamics consistent with pre-capillary PH who can give informed consent are ideal candidates.

Probably not a fit

Patients with predominant non-CTEPH pulmonary hypertension, severe parenchymal lung disease, uncontrolled comorbidities, poor-quality tracings or arrhythmias that prevent reliable waveform analysis, or contraindications to BPA or contrast are unlikely to benefit from these measurements.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective observational protocol that records pulmonary artery pressure waveforms during routine balloon pulmonary angioplasty and applies wave intensity analysis (WIA) and reservoir-excess pressure analysis (REPA). Patients receive standard-of-care BPA and undergo serial assessments including 6-minute walk distance, NT-proBNP, RV strain by echocardiography, and quality-of-life questionnaires. The waveform-derived pulsatile metrics will be compared to conventional steady-flow hemodynamics (mPAP, PVR) to see which metrics best track multidimensional clinical improvement. No extra invasive procedures are required beyond the catheter recordings obtained during planned BPA sessions.

Why it matters

Potential benefit: If successful, these waveform measures could give clinicians a more sensitive way to monitor and predict functional and right-heart recovery after BPA, allowing better tailored follow-up and treatment decisions.

How similar studies have gone: Wave-based hemodynamic methods have shown promise in systemic arterial research and small pulmonary studies, but applying WIA and REPA to predict BPA outcomes in CTEPH is largely novel with limited prior clinical data.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 18-85 years.

Confirmed diagnosis of CTEPH by a multidisciplinary CTEPH team and deemed eligible for BPA.

Hemodynamics compatible with pre-capillary PH according to current guidelines, as assessed by RHC (Right Heart Catheterization).

Technically inoperable CTEPH or persistent/recurrent PH following PEA (Pulmonary Endarterectomy).

Written informed consent.

Exclusion Criteria:

* Predominant diagnosis of PH other than CTEPH or concomitant severe parenchymal lung disease.

Active infection, uncontrolled systemic disease, active malignancy, or life expectancy \< 12 months.

Pregnant or lactating patients.

Advanced renal failure (e.g., eGFR \< 30 \\text{ mL/min/1.73 m\^2}) or contraindications to contrast media (per institutional routine).

Inadequate image quality precluding reliable echocardiographic analysis.

Pressure tracings with significant artifacts hindering analysis or uncontrolled arrhythmia (e.g., atrial fibrillation with rapid ventricular response).

Decompensated or hemodynamically unstable patients.

Any other condition deemed clinically unsuitable by the investigator.

Where it's running

  • Istanbul Mehmet Akif Ersoy Educational and Training Hospital
    Istanbul, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.